The Affordable Insulin Now Act (H.R. 6255) would extend the $35 insulin cap to all Americans with private insurance.
Extend the $35 insulin cap to all Americans with private insurance.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
AP reports that a new bipartisan INSULIN Act was introduced on April 2, 2026 to cap insulin at $35 per month for Americans with private insurance, and notes that a similar 2022 House-passed effort did not clear the Senate.
legacy_unverified · Source version not recorded · locator unknown
The House Clerk shows H.R. 6833, the Affordable Insulin Now Act, passed the House 232-193 on March 31, 2022; Steven Horsford voted Yea.
legacy_unverified · Source version not recorded · locator unknown
Axios reported that Senate Republicans blocked the proposed $35 insulin cap for patients with private insurance from being included in the 2022 reconciliation bill, leaving the private-insurance version out of the package.
legacy_unverified · Source version not recorded · locator unknown
Medicare.gov currently says covered insulin costs no more than $35 for a one-month supply of each Part B- and Part D-covered insulin product, confirming the federal cap exists for Medicare coverage.
Assessments
Horsford supported the promised policy by voting for the 2022 Affordable Insulin Now Act after the House passed a $35 insulin cap that included private insurance, so he made a meaningful legislative attempt. But the private-insurance cap did not become federal law: Senate action stripped or blocked that provision, and the enacted federal $35 cap applies to Medicare rather than all Americans with private insurance. Continued 2026 efforts to pass a private-insurance cap further indicate the promised outcome remains undelivered.